Quarterly report pursuant to Section 13 or 15(d)

Segments - Operations and Assets Information (Details)

v3.20.2
Segments - Operations and Assets Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Segment Reporting Information [Line Items]          
Total revenues $ 301,207 $ 226,368 $ 512,674 $ 448,820  
Operating loss 27,179 (47,260) (13,581) (122,577)  
Depreciation and amortization 22,266 23,661 44,318 47,477  
Net income (loss) from investment in investees (189) (271) (323) (2,125)  
Assets 2,323,734   2,323,734   $ 2,309,272
Goodwill 671,599   671,599   671,940
United States          
Segment Reporting Information [Line Items]          
Total revenues 265,890 184,310 446,761 369,203  
Ireland          
Segment Reporting Information [Line Items]          
Total revenues 16,847 22,174 28,749 42,707  
Chile          
Segment Reporting Information [Line Items]          
Total revenues 11,152 9,051 22,002 16,915  
Spain          
Segment Reporting Information [Line Items]          
Total revenues 4,136 4,876 8,292 9,294  
Israel          
Segment Reporting Information [Line Items]          
Total revenues 1,183 3,768 2,890 6,884  
Mexico          
Segment Reporting Information [Line Items]          
Total revenues 1,866 2,058 3,708 3,589  
Other          
Segment Reporting Information [Line Items]          
Total revenues 133 131 272 228  
Corporate          
Segment Reporting Information [Line Items]          
Operating loss (7,760) (10,691) (16,263) (22,962)  
Depreciation and amortization 0 19 59 39  
Net income (loss) from investment in investees 0 0 0 0  
Assets 54,381   54,381   99,521
Goodwill 0   0   0
Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Operating loss (5,996) (8,556) (20,121) (38,033)  
Depreciation and amortization 7,119 7,382 14,240 14,908  
Net income (loss) from investment in investees (189) (271) (323) (2,125)  
Assets 1,148,151   1,148,151   1,174,639
Goodwill 236,790   236,790   237,131
Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Operating loss 40,935 (28,013) 22,803 (61,582)  
Depreciation and amortization 15,147 16,260 30,019 32,530  
Net income (loss) from investment in investees 0 0 0 0  
Assets 1,121,202   1,121,202   1,035,112
Goodwill 434,809   434,809   $ 434,809
Services          
Segment Reporting Information [Line Items]          
Total revenues 250,971 178,458 421,811 357,349  
Services | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Services | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Services | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 250,971 178,458 421,811 357,349  
Products          
Segment Reporting Information [Line Items]          
Total revenues 29,356 28,680 60,430 53,981  
Products | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 29,356 28,680 60,430 53,981  
Transfer of intellectual property and other          
Segment Reporting Information [Line Items]          
Total revenues 20,880 19,230 30,433 37,490  
Transfer of intellectual property and other | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Transfer of intellectual property and other | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 14,686 19,230 24,239 37,490  
Transfer of intellectual property and other | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues $ 6,194 $ 0 $ 6,194 $ 0